Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Genus Pharmaceuticals Holding Limited, T/A Genus Pharmaceuticals, Linthwaite, Huddersfield, HD7 5QH, UK
Lormetazepam Tablets 0.5 mg.
or
Dormagen Tablets 0.5mg.
| Pharmaceutical Form |
|---|
|
Lormetazepam Tablets 0.5mg are round white tablets, 6.5mm in diameter with ‘GP036’ embossed on one side and plain on the other. |
Lormetazepam Tablets 0.5mg contain 0.5mg lormetazepam.
Lormetazepam (INN, BAN) is chemically defined as 7-chloro-5-(2-chlorophenyl)- 1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one.
| Active Ingredient | Description | |
|---|---|---|
| Lormetazepam |
Lormetazepam is a benzodiazepine with anxiolytic, muscle relaxant, sedative and hypnotic properties. Clinical studies have shown minimal effects on REM sleep and on psychomotor performance on the day after treatment with lormetazepam. Lormetazepam is indicated for the short term treatment of insomnia. |
| List of Excipients |
|---|
|
Lactose |
PVC/aluminium foil blister packs: Pack sizes of 28, 30 or 100 tablets.
Opaque polypropylene Securitainers: Pack sizes of 28, 30 or 100 tablets.
Amber glass bottles: Pack sizes of 28, 30 or 100 tablets.
Genus Pharmaceuticals Holding Limited, T/A Genus Pharmaceuticals, Linthwaite, Huddersfield, HD7 5QH, UK
PL 17225/0012
10/03/2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
